New Delhi: Minister of State for Road Transport & Highways, Shipping and Chemicals & Fertilizers Mansukh L Mandaviya, in a written reply to a question in Rajya Sabha today, informed that the Union government had taken a number of stringent steps to check the quality of drugs available in the country.
Replying to the question on the status of quality of drugs available in India, Mandaviya said that, in the National Drug Survey conducted in the year 2014-16, 3.16 % of drugs were found not of standard quality (NSQ). The Minister further stated that the test reports of the drug samples declared as NSQ were forwarded to the State licensing authorities concerned with a request to take appropriate action and also legal samples of the same batch of drugs for testing.
The minister detailed the stringent steps taken by Government of India to check the quality of drugs available in the country. The Drugs and Cosmetics Act, 1940 was amended under Drugs & Cosmetics (Amendment) Act 2008 to provide stringent penalties for the manufacture of spurious and adulterated drugs. Certain offences have also been made cognisable and non-bailable.
The States and Union Territories were requested to set up special courts for trial of offences under the Drugs and Cosmetics Act for speedy disposal. So far, 22 States have already set up designated special courts.
A whistle blower scheme was announced by the Centre to encourage vigilant public participation in the detection of movement of spurious drugs in the country. The scheme provides for suitably rewarding the informers for providing concrete information to the regulatory authorities in respect of the movement of spurious drugs. The details of policy are available on the website of CDSCO.
Guidelines for taking action on samples of drugs declared spurious or not of standard quality in the light of enhanced penalties under the Drugs & Cosmetics (Amendment) Act, 2008, were forwarded to the State drugs controllers for uniform implementation.
The inspectors have been instructed to keep a vigil and draw samples of drugs for test and analysis to monitor the quality of drugs moving in the country.
The number of sanctioned posts in CDSCO has been increased from 111 in 2008 to 510 in 2017.
The testing capacities of Central Drugs Testing Laboratories under CDSCO are being constantly strengthened to expedite testing of drug samples in the country.
The Union government has decided to strengthen both the central and State drug regulatory systems during the 12th Five Year Plan enabling them to keep more effective watch on unscrupulous elements indulging in unlawful activities relating to the quality of drugs.
The Cabinet Committee on Economic Affairs (CCEA) has approved the proposal for strengthening the drug regulatory system in the country, both under the Union and State governments, at a total expenditure of Rs 1,750 crores. Out of this, Rs 850 crore is the Centre’s share. The shares of the Centre and the States in terms of components of each will be in the ratio of 60:40 for all States except Jammu & Kashmir, Himachal Pradesh, Uttarakhand, Sikkim and the north-eastern States, for which the ratio will be 90:10.
- IMA strongly opposes draft bill that seeks to replace MCI - 17 December 2017
- कोयला घोटाला- मधु कोड़ा को तीन साल की सजा, 25 लाख जुर्माना - 16 December 2017
- BJP terms Congress as a ‘corrupt thought process’ - 16 December 2017
- Rahul’s leadership brings a new sense of dedication: Manmohan - 16 December 2017
- US may stop work authorisation to spouses of H-1B visa holders - 16 December 2017